PLx Pharma Q2 Loss Top Estimates, But Revenues Miss; Stock Down 15%
(RTTNews) - PLx Pharma Inc. (PLXP) reported Friday a second-quarter net loss attributable to common shareholders of $11.56 million or $0.43 per share, narrower than $18.71 million or $0.79 per share in the prior-year quarter.
Excluding items, adjusted loss for the quarter were $0.52 per share, compared to adjusted loss of $0.27 per share in the year-ago quarter.
Total revenues for the quarter were $0.48 million, compared to nil in the same quarter last year.
On average, three analysts polled by Thomson Reuters expected the company to report a loss of $0.56 per share on revenues of $3.5 million for the quarter. Analysts' estimates typically exclude special items.
The company said it has recently engaged Raymond James & Associates, Inc. as financial advisor to commence a formal process to evaluate strategic alternatives to enhance stockholder value with the full support from the Board.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
TSX Ends On Firm Note
Swiss Market Ends On Firm Note
U.S. Dollar Lower As Soft Jobs Data Lifts Rate Cut Hopes
European Stocks Close Higher As Investors React To Earnings, Economic Data
Canadian Market Firmly Up In Positive Territory
U.S. Service Sector Activity Contracts For First Time Since December 2022
Eurozone Unemployment Rate Steady At 6.5% For Fifth Month
